来自MSN1 个月
First paediatric patient recruited for Dimerix’s ACTION3 kidney disease drug trial
Consequently, DMX-200 has been granted Orphan Drug Designation in the US and Europe, as well as the equivalent Innovative Licensing and Access Pathway (ILAP) designation in the UK. FSGS is one of ...
heraldsun.com.au1 个月
Dimerix inks lucrative licensing deal for kidney drug in Japan
Consequently, DMX-200 has been granted Orphan Drug Designation in the US and Europe, as well as the equivalent Innovative Licensing and Access Pathway (ILAP) designation in the UK. Fuso is the ...